查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942595

2026年全球先天性心臟疾病器材市场报告

Congenital Heart Defect Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，先天性心臟疾病器材市场发展迅速，预计将以7.4%的复合年增长率成长，从2025年的31.1亿美元成长到2026年的33.4亿美元。过去几年的成长可归因于多种因素，包括先天性心臟疾病发病率的上升、儿童心臟外科手术的进步、先天性心臟疾病患者生存率的提高、专业心臟护理中心的扩张以及人们对先天性心臟病早期诊断意识的增强。

预计未来几年，先天性心臟疾病器材市场将维持强劲成长，到2030年市场规模将达到44.5亿美元，复合年增长率（CAGR）为7.4%。预测期内的成长要素包括：对早期诊断和治疗的日益重视、对微创儿童心臟手术需求的增长、新兴市场先进心臟护理服务的普及、先天性心臟疾病成人患者群体的不断扩大，以及植入式心臟器械技术的持续创新。预测期内的主要趋势包括：微创先天性心臟病心血管手术的日益普及、经导管和植入式心臟器械的广泛应用、对婴儿童心臟介入治疗的日益重视、针对复杂心臟缺陷的器械治疗的扩展，以及对长期心臟监测和支持设备需求的增长。

先天性心臟疾病器械市场的成长预计将受到微创手术数量不断增加的推动。这些手术透过微小切口或自然腔道，利用专用器械和技术进行，以最大程度地减少创伤并加快恢復。微创手术数量增加的因素包括技术进步、患者对微创治疗的偏好、手术技术的改进以及恢復时间更短、併发症更少等优势。先天性心臟疾病器械在这些手术中发挥关键作用，因为它们能够透过更小的切口和导管介入的方式对心臟异常进行诊断、治疗和管理。例如，根据美国整形外科医师协会 (ASPS) 的数据，截至 2024 年 6 月，2023 年整形手术数量年增 5%，而微创手术数量较去年同期增加 7%。微创手术的成长反过来又推动了先天性心臟疾病治疗器械市场的扩张。

先天性心臟疾病(CHD) 器材市场的主要企业正在加强策略联盟，以开发创新解决方案。这些联盟透过汇集资源和专业知识、强化研发、拓展市场覆盖率以及加速商业化进程，为 CHD 器材领域的公司提供支援。此类合作促进创新，并推动产业成长。例如，2024 年 5 月，总部位于印度的製造公司 Sahajanand Medical Technologies Pvt Ltd (SMT) 与印度医疗技术公司 HeartX 达成合作，旨在改善心血管领域的患者照护。此次合作将使 Sahajanand Medical Technologies (SMT) 能够透过整合 HeartX 的尖端解决方案（例如 JOVE VB 支架）来增强其在 CHD 市场的地位。此次合作将使 SMT 能够提供先进的 CHD 器械，从而提高治疗效果、简化手术流程并改善患者预后。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球先天性心臟疾病器材市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 微创先天性心血管手术的普及率不断提高
    • 经导管和植入式心臟装置的使用日益增多
    • 越来越重视婴幼儿儿童的心臟介入治疗
    • 扩大以器械为基础的复杂心臟畸形治疗方法
    • 长期心臟监测和辅助设备的需求不断增长

第五章 终端用户产业市场分析

  • 医院
  • 专科心臟诊所
  • 儿童心臟病中心
  • 心臟外科中心
  • 学术研究机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球先天性心臟疾病器材市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球先天性心臟疾病器材市场规模、比较及成长率分析
  • 全球先天性心臟疾病器材市场表现：规模与成长，2020-2025年
  • 全球先天性心臟疾病器材市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依设备类型
  • 导管、心律调节器、植入式心臟整流去颤器、植入式心臟循环记录器和其他装置类型
  • 按缺陷类型
  • 心房中膈缺损症、室间隔缺损、房室间隔缺损、三尖瓣闭锁、动脉干畸形及其他类型的缺损
  • 最终用户
  • 医院、专科诊所、学术研究机构和其他最终用户
  • 按类型细分：导管
  • 球囊导管、诊断导管、引导管
  • 按类型细分：心臟起搏器
  • 单腔心律调节器、双腔心律调节器、双心室节律器、无导线心律调节器
  • 依类型细分：植入式心臟整流去颤器
  • 单腔ICD、双腔ICD、皮下ICD
  • 依类型细分：双心室装置
  • CRT-P（心臟再同步治疗心律调节器）、CRT-D（心臟再同步治疗去心房颤动）
  • 按类型细分：植入式心臟循环记录仪
  • 传统植入式循环记录仪，皮下植入式循环记录仪
  • 按类型细分：其他设备类型
  • 经导管心臟瓣膜、心室辅助装置（VADS）

第十章 区域与国家分析

  • 全球先天性心臟疾病器材市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球先天性心臟疾病器材市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 先天性心臟疾病器材市场：竞争格局及市场占有率（2024年）
  • 先天性心臟疾病器材市场：公司估值矩阵
  • 先天性心臟疾病器材市场：公司概况
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Boston Scientific Corporation
    • WL Gore & Associates Inc

第37章：其他领先和创新企业

  • Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年先天性心臟疾病器材市场：提供新机会的国家
  • 2030年先天性心臟疾病器材市场：充满新机会的细分市场
  • 2030年先天性心臟疾病器材市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCHDD01_G26Q1

Congenital heart defect devices are specialized medical instruments and implants designed to address and manage heart abnormalities present from birth. These devices are used to diagnose, treat, and support the heart's function in individuals with congenital heart defects, aiming to restore normal blood flow and enhance cardiac performance.

The primary types of congenital heart defect devices include catheters, pacemakers (single-chamber, dual-chamber, biventricular, and leadless), implantable cardioverter defibrillators, biventricular devices, and implanted cardiac loop recorders. Catheters are slender, flexible tubes inserted into the body for various functions such as diagnostic, therapeutic, or monitoring purposes. These devices are used for different types of congenital defects, including ventricular septal defect, atrioventricular septal defect, tricuspid atresia, truncus arteriosus, and others. They are employed by hospitals, specialty clinics, academic and research institutions, and other healthcare settings.

Tariffs are impacting the congenital heart defect devices market by increasing costs for imported medical-grade materials, electronic components, and precision-engineered parts used in pacemakers, catheters, and implantable cardiac devices. These cost pressures have particularly affected advanced implantable and transcatheter device segments, with north america and europe experiencing higher exposure due to complex global supply chains. Increased tariffs have raised procurement costs for hospitals and specialty clinics. However, tariffs have also encouraged localized manufacturing, supplier diversification, and regional production expansion, strengthening long-term supply chain resilience.

The congenital heart defect devices market research report is one of a series of new reports from The Business Research Company that provides congenital heart defect devices market statistics, including congenital heart defect devices industry global market size, regional shares, competitors with a congenital heart defect devices market share, detailed congenital heart defect devices market segments, market trends and opportunities, and any further data you may need to thrive in the congenital heart defect devices industry. This congenital heart defect devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart defect devices market size has grown strongly in recent years. It will grow from $3.11 billion in 2025 to $3.34 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising incidence of congenital heart defects, advancements in pediatric cardiac surgery, increasing survival rates of congenital heart patients, expansion of specialized cardiac care centers, growing awareness of early congenital defect diagnosis.

The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing focus on early diagnosis and intervention, rising demand for minimally invasive pediatric cardiac treatments, expanding access to advanced cardiac care in emerging markets, growing population of adults with congenital heart disease, continuous innovation in implantable cardiac devices. Major trends in the forecast period include rising adoption of minimally invasive congenital heart procedures, increasing use of transcatheter and implantable cardiac devices, growing focus on early-life and pediatric cardiac interventions, expansion of device-based therapies for complex heart defects, increasing demand for long-term cardiac monitoring and support devices.

The growth of the congenital heart defect device market is anticipated to be driven by the rising number of minimally invasive procedures. These procedures involve performing surgeries through small incisions or natural body openings, using specialized tools and techniques to minimize trauma and improve recovery. Factors contributing to the increase in minimally invasive procedures include technological advancements, patient preference for less invasive treatments, enhanced surgical techniques, and the advantages of reduced recovery times and complications. Congenital heart defect devices play a crucial role in these procedures by enabling the diagnosis, treatment, and management of heart abnormalities through smaller incisions or catheter-based approaches. For example, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, plastic surgeries in 2023 increased by 5%, while minimally invasive procedures grew by 7% compared to the previous year. This rise in minimally invasive procedures is consequently boosting the congenital heart defect device market.

Major players in the congenital heart defect (CHD) devices market are increasingly forming strategic partnerships to develop innovative solutions. These partnerships help companies in the CHD devices sector by combining resources and expertise, enhancing research and development efforts, expanding market reach, and accelerating the commercialization process. Such collaborations foster innovation and contribute to industry growth. For example, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing company, entered into a partnership with HeartX, an India-based MedTech firm, to improve patient care in the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its presence in the CHD market by incorporating HeartX's cutting-edge solutions, such as the JOVE VB Stent. This alliance enables SMT to provide advanced CHD devices that improve treatment effectiveness, simplify procedures, and enhance patient outcomes.

In June 2023, Translumina Therapeutics LLP, an India-based cardiovascular device manufacturer, acquired Wellinq Group Company for an undisclosed sum. This acquisition aims to broaden Translumina's cardiovascular and endovascular solutions portfolio and strengthen its market presence in the Netherlands by integrating Blue Medical Devices' innovative technologies and expertise. Wellinq Group Company, based in the Netherlands, specializes in developing and manufacturing products for treating congenital heart defects.

Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart defect devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The congenital heart defect devices market consists of sales of septal occluders, heart valves, patent ductus arteriosus (PDA) devices, and bioprosthetic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Defect Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses congenital heart defect devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart defect devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The congenital heart defect devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Catheters; Pacemakers; Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers; Implantable Cardioverter Defibrillators; Biventricular Devices; Implanted Cardiac Loop Recorders; Other Device Types
  • 2) By Defect Type: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect; Tricuspid Atresia; Truncus Arteriosus; Other Defect Types
  • 3) By End user: Hospitals; Specialty Clinics; Academic And Research Institute; Other End Users
  • Subsegments:
  • 1) By Catheters: Balloon Catheters; Diagnostic Catheters; Guiding Catheters
  • 2) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers; Leadless Pacemakers
  • 3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds; Dual-Chamber Icds; Subcutaneous Icds
  • 4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers); Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders; Subcutaneous Implantable Loop Recorders
  • 6) By Other Device Types: Transcatheter Heart Valves; Ventricular Assist Devices (VADS)
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; W L Gore & Associates Inc; Lepu Medical Technology Beijing Co Ltd; MicroPort Scientific Corporation; Berlin Heart GmbH; Syncardia Systems LLC; Occlutech Holding AG; Sahajanand Medical Technologies Pvt Ltd; Xeltis AG; Procyrion Inc; Heartstitch Inc; Cardia Inc; OSYPKA Medical GmbH; On-X Life Technologies Inc; Ventracor Limited; HemoFlow Technologies; NuPulseCV Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Congenital Heart Defect Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Congenital Heart Defect Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Congenital Heart Defect Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Congenital Heart Defect Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Minimally Invasive Congenital Heart Procedures
    • 4.2.2 Increasing Use Of Transcatheter And Implantable Cardiac Devices
    • 4.2.3 Growing Focus On Early-Life And Pediatric Cardiac Interventions
    • 4.2.4 Expansion Of Device-Based Therapies For Complex Heart Defects
    • 4.2.5 Increasing Demand For Long-Term Cardiac Monitoring And Support Devices

5. Congenital Heart Defect Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Cardiac Clinics
  • 5.3 Pediatric Cardiology Centers
  • 5.4 Cardiac Surgery Centers
  • 5.5 Academic And Research Institutes

6. Congenital Heart Defect Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Congenital Heart Defect Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Congenital Heart Defect Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Congenital Heart Defect Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Congenital Heart Defect Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Congenital Heart Defect Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Congenital Heart Defect Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Congenital Heart Defect Devices Market Segmentation

  • 9.1. Global Congenital Heart Defect Devices Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Catheters, Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
  • 9.2. Global Congenital Heart Defect Devices Market, Segmentation By Defect Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
  • 9.3. Global Congenital Heart Defect Devices Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
  • 9.4. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Balloon Catheters, Diagnostic Catheters, Guiding Catheters
  • 9.5. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
  • 9.6. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
  • 9.7. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
  • 9.8. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Implanted Cardiac Loop Recorders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
  • 9.9. Global Congenital Heart Defect Devices Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcatheter Heart Valves, Ventricular Assist Devices (VADS)

10. Congenital Heart Defect Devices Market Regional And Country Analysis

  • 10.1. Global Congenital Heart Defect Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Congenital Heart Defect Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Congenital Heart Defect Devices Market

  • 11.1. Asia-Pacific Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Congenital Heart Defect Devices Market

  • 12.1. China Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Congenital Heart Defect Devices Market

  • 13.1. India Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Congenital Heart Defect Devices Market

  • 14.1. Japan Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Congenital Heart Defect Devices Market

  • 15.1. Australia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Congenital Heart Defect Devices Market

  • 16.1. Indonesia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Congenital Heart Defect Devices Market

  • 17.1. South Korea Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Congenital Heart Defect Devices Market

  • 18.1. Taiwan Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Congenital Heart Defect Devices Market

  • 19.1. South East Asia Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Congenital Heart Defect Devices Market

  • 20.1. Western Europe Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Congenital Heart Defect Devices Market

  • 21.1. UK Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Congenital Heart Defect Devices Market

  • 22.1. Germany Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Congenital Heart Defect Devices Market

  • 23.1. France Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Congenital Heart Defect Devices Market

  • 24.1. Italy Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Congenital Heart Defect Devices Market

  • 25.1. Spain Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Congenital Heart Defect Devices Market

  • 26.1. Eastern Europe Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Congenital Heart Defect Devices Market

  • 27.1. Russia Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Congenital Heart Defect Devices Market

  • 28.1. North America Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Congenital Heart Defect Devices Market

  • 29.1. USA Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Congenital Heart Defect Devices Market

  • 30.1. Canada Congenital Heart Defect Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Congenital Heart Defect Devices Market

  • 31.1. South America Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Congenital Heart Defect Devices Market

  • 32.1. Brazil Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Congenital Heart Defect Devices Market

  • 33.1. Middle East Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Congenital Heart Defect Devices Market

  • 34.1. Africa Congenital Heart Defect Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Congenital Heart Defect Devices Market, Segmentation By Device Type, Segmentation By Defect Type, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Congenital Heart Defect Devices Market Regulatory and Investment Landscape

36. Congenital Heart Defect Devices Market Competitive Landscape And Company Profiles

  • 36.1. Congenital Heart Defect Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Congenital Heart Defect Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Congenital Heart Defect Devices Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. W L Gore & Associates Inc Overview, Products and Services, Strategy and Financial Analysis

37. Congenital Heart Defect Devices Market Other Major And Innovative Companies

  • Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

38. Global Congenital Heart Defect Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Congenital Heart Defect Devices Market

40. Congenital Heart Defect Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Congenital Heart Defect Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Congenital Heart Defect Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Congenital Heart Defect Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer